Not Signed In - AVN944 Inhibits IMPDH & Induces Apoptosis-related Biomarkers In Patients With Hematologic Cancers
Fri, 15 Dec 2006 09:00 AM EST
... Avalon Pharmaceuticals, Inc. (NASDAQ and NYSE Arca: AVRX), presented a poster detailing the effect of AVN944 on a comprehensive set of genetic and biochemical biomarkers at the American Society of Hematology 48th Annual Meeting. [click link for full article] ...
Related Topics
- AIDS-Related Cancers
- Cardiac Biomarkers
- What Your Female Patients Want to Know About Bladder Control
- Vaccinations For HIV/AIDs Patients
- Smoking Cessation and Continued Risk in Cancer Patients
- Unusual Childhood Cancers
- Unusual Cancers of Childhood
- Schistosomiasis
- Water-Related Diseases
- Food-Related Diseases
- Macular Degeneration
- Lymphoma, AIDS-Related
- AIDS-Related Lymphoma
- Quality of Life, Health-Related
- Health-Related Quality of Life
- Sports Injury
- Sports Injuries
- Autoimmune Diseases
- Musculoskeletal Disorders
- Heat-Related Illness
email this page
print this page
bookmark this page
feedback on this page
